Geoffrey T. Yarranton
2013
In 2013, Geoffrey T. Yarranton earned a total compensation of $670.1K as Chief Scientific Officer at KaloBios Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $140,044 |
|---|---|
| Option Awards | $242,588 |
| Salary | $287,500 |
| Total | $670,132 |
Yarranton received $287.5K in salary, accounting for 43% of the total pay in 2013.
Yarranton also received $140K in non-equity incentive plan and $242.6K in option awards.
Rankings
In 2013, Geoffrey T. Yarranton's compensation ranked 8,322nd out of 12,286 executives tracked by ExecPay. In other words, Yarranton earned more than 32.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,322 out of 12,286 | 32nd |
Division Manufacturing | 3,018 out of 4,612 | 35th |
Major group Chemicals And Allied Products | 943 out of 1,462 | 36th |
Industry group Drugs | 717 out of 1,156 | 38th |
Industry Pharmaceutical Preparations | 566 out of 890 | 36th |
Source: SEC filing on April 29, 2014.
Yarranton's colleagues
We found two more compensation records of executives who worked with Geoffrey T. Yarranton at KaloBios Pharmaceuticals in 2013.